Human renal-cell carcinoma tissue contains dendritic cells

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 1-7

  Thurnher, Martin ^a   Radmayr, Christian ^a   Ramoner, Reinhold ^a   Ebner, Susanne ^a   Böck, Günther ^b   Klocker, Helmut ^a   Romani, Nikolaus ^a   Bartsch, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; ARTICLE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, T-INDEPENDENT; CARCINOMA, RENAL CELL; DENDRITIC CELLS; DEXTRANS; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; ORGAN CULTURE TECHNIQUES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0029903790     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<1::AID-IJC1>3.0.CO;2-V     Document Type: Article

References (31)

1. AUSTYN, J.M., HANKINS, D.F., LARSEN, C.P., MORRIS, P.J., RAO, A.S. and ROAKE, J.A., Isolation and characterization of dendritic cells from mouse heart and kidney. J. Immunol., 152, 2401-2410 (1994).
2. BUELENS, C., WILLEMS, F., DELVAUX, A., PIÉRARD, G., DELVILLE, J.-P., VELU, T. and GOLDMAN, M., Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Europ. J. Immunol., 25, 2568-2672 (1995).
3. CAUX, C., DEZUTTER-DAMBUYANT, C., SCHMITT, D. and BANCHEREAU, J., GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360, 258-261 (1992).
4. CAUX, C., VANBERVLIET, B., MASSACRIER, C., AZUMA, M., OKUMURA, M., LANIER, L.L. and BANCHEREAU, J., B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. exp. Med., 180, 1841-1847 (1994).
5. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53, 5613-5616 (1993).
6. GUINAN, E.G., GRIBBEN, J.G., BOUSSIOTIS, V.A., FREEMAN, G.J. and NADLER, L.M., Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 3261-3282 (1994).
7. HEUFLER, C., TOPAR, G., KOCH, F., TROCKENBACHER, B., KÄMPGEN, E., ROMANI, N. and SCHULER, G., Cytokine gene expression in murine epidermal cell suspensions: interleukin-1α and macrophage inflammatory protein la are selectively expressed in Langerhans cells but are differentially regulated in culture. J. exp. Med., 176, 1221-1226 (1992).
8. INABA, K., INABA, M., DEGUCHI, M., HAGI, E., YASUMIZU, R., IKEHARA, S., MURAMATSU, S. and STEINMAN, R.M., Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class-II-negative progenitor in mouse bone marrow. Proc. nat. Acad. Sci. (Wash.), 90, 3038-3042 (1993).
9. INABA, K., WITMER-PACK, M., INABA, M., HATHCOCK, K.S., SAKUTA, H., AZUMA, M., YAGITA, H., OKUMURA, K., LINSLEY, P.S., IKEHARA, S., MURAMATSU, S., HODES, R.J. and STEINMAN, R.M., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. exp. Med., 180, 1849-1860 (1994).
10. JANEWAY, C.A., JR. and BOTTOMLY, K., Signals and signs for lymphocyte responses. Cell, 76, 275-285 (1994).
11. KLEIN, E.A., BUKOWSKI, R.M. and FINKE, J.H., Renal cell carcinoma: immunotherapy and cellular biology. Marcel Dekker, New York (1993).
12. LENZ, A., HEINE, M., SCHULER, G. and ROMANI, N., Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. clin. Invest., 92, 2587-2596 (1993).
13. LU, L., WOO, J., RAO, A.S., LI, Y., WATKINS, S.C., QIAN, S., STARZL, T.E., DEMETRIS, A.J. and THOMSON, A.W., Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J. exp. Med., 179, 1823-1834 (1994).
14. LUDEWIG, B., GRAF, D., GELDERBLOM, H.R., BECKER, Y., KROCZEK, R.A. and PAULI, G., Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-a, but strongly enhanced by interleukin-10. Europ. J. Immunol., 25, 1943-1950 (1995).
15. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., KAST, W.M., DELEO, A.B. and LOTZE, M.T., Bone-marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med., 1, 1297-1302 (1995).
16. MCWILLIAM, A.S., NELSON, D., THOMAS, J.A. and HOLT, P.G., Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. exp. Med., 179, 1331-1336 (1994).
17. MITRA, R.S., JUDGE, T.A., NESTLE, F.O., TURKA, L.A. and NICKOLOFF, B.J., Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol., 154, 2668-2677 (1995).
18. NAKAGOMI, H., PISA, P., PISA, E.K., YAMAMOTO, Y., HALAPI, E., BACKLIN, K., JUHLIN, C. and KIESSLING, R., Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal-cell carcinoma. Int. J. Cancer, 63, 366-371 (1995).
19. POPE, M., BETJES, M.G.H., HIRMAND, H., HOFFMAN, L. and STEINMAN, R.M., Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J. invest. Dermatol., 104, 11-17 (1995).
20. ROAKE, J., RAO, A.S., MORRIS, P.J., LARSEN, C.P., HANKINS, D.F. and AUSTYN, J.M., Dendritic cell loss from nonlymphoid tissue after systemic administration of lipopolysaccharide, tumor necrosis factor, and inlerleukin-1. J. exp. Med., 181, 2237-2247 (1995).
21. ROMANI, N., GRUNER, S., BRANG, D., KÄMPGEN, E., LENZ, A., TROCKENBACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M. and SCHULER, G., Proliferating dendritic cell progenitors in human blood. J. exp. Med., 180, 83-93 (1994).
22. SALLUSTO, F., CELLA, M., DANIELI, C. and LANZAVECCHIA, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. exp. Med., 182, 389-400 (1995).
23. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte / macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor α. J. exp. Med., 179, 1109-1118 (1994).
24. SOZZANI, S., SALLUSTO, F., LUINI, W., ZHOU, D., PIEMONTI, L., ALLAVENA, P., VAN DAMME, J., VALITUTTI, S., LANZAVECCHIA, A. and MANTOVANI, A., Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol., 155, 3292-3295 (1995).
25. STEINMAN, R., HUFFMAN, L. and POPE, M., Maturation and migration of cutaneous dendritic cells. J. invest. Dermatol., 105, 2S-7S (1995).
26. STEINMAN, R.M., The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9, 271-297 (1991).
27. THURNHER, M., RADMAYR, C., HOBISCH, A., BÖCK, G., ROMANI, N., BARTSCH, G. and KLOCKER, H., T lymphocytes from renal cell carcinoma express B7-1 (CD80): T cell expansion by T-T cell costimulation. Int. J. Cancer, 62, 559-564 (1995).
28. WHITESIDE, T.L. and PARMIANI, G., Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother., 39, 15-21 (1994).
29. YOUNG, J.W. and INABA, K., Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. exp. Med., 183, 7-11 (1996).
30. ZHOU, L.-J. and TEDDER, T.F., Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154, 3821-3835 (1995a).
31. + blood dendritic cells. Blood, 86, 3295-3301 (1995b).